Latest Breaking News On - Salarius pharmaceuticalssalarius pharmaceuticals - Page 1 : comparemela.com

Salarius Pharmaceuticals Announces $6 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Salarius Pharmaceuticals Announces $6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRelationskim sutton golodetzMd anderson cancer centerProduct development awardResearch institute of texasHc wainwright coSalarius pharmaceuticalssalarius pharmaceuticals incNational pediatric cancer foundationSalarius pharmaceuticals incExchange commissionDrug administrationWall streetSecurities actSalarius pharmaceuticalssalarius pharmaceuticalsCancer preventionResearch institute

Salarius Pharmaceuticals (SLRX) Announces $6 Million Private Placement of Common Stock, Warrants

Salarius Pharmaceuticals (SLRX) Announces $6 Million Private Placement of Common Stock, Warrants
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesProduct development awardExchange commissionResearch institute of texasNational pediatric cancer foundationSalarius pharmaceuticalssalarius pharmaceuticals incDrug administrationSalarius pharmaceuticals incHc wainwright coMd anderson cancer centerSecurities actSalarius pharmaceuticalssalarius pharmaceuticalsCancer preventionResearch institute

Salarius (SLRX) Announces FDA Removes Partial Clinical Hold on Phase 1/2 Trial of Seclidemstat

Salarius (SLRX) Announces FDA Removes Partial Clinical Hold on Phase 1/2 Trial of Seclidemstat
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sankt peterburgNew yorkUnited statesDana farber cancer instituteFox chase cancer centerMemorial sloan kettering cancer centerRelationskim sutton golodetzDavid arthurLos angelesInternational conventionProduct development awardWashington university in stOregon health sciences university in portlandSalarius pharmaceuticalssalarius pharmaceuticals incSalarius pharmaceuticals incResearch institute of texas

Salarius Pharmaceuticals (SLRX) Reports No Adverse Safety Signals from Two Toxicology Studies of SP-3164

Salarius Pharmaceuticals (SLRX) Reports No Adverse Safety Signals from Two Toxicology Studies of SP-3164
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRelationskim sutton golodetzDavid arthurExchange commissionDrug administrationSalarius pharmaceuticals incResearch institute of texasGood laboratory practiceAmerican association for cancer research annual meetingProduct development awardNational pediatric cancer foundationAmerican society for hematology annual meetingMd anderson cancer centerSalarius pharmaceuticalssalarius pharmaceuticals incInvestigational new drugHodgkin lymphomas

Salarius Pharmaceuticals to Present at the Diamond Equity Research Emerging Growth Invitational Conference

Salarius Pharmaceuticals to Present at the Diamond Equity Research Emerging Growth Invitational Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDaniela santiestebanAundrietta duncanMark rosenblumRelationskim sutton golodetzResearch institute of texasProduct development awardDiamond equity research emerging growth invitationaldateNational pediatric cancer foundationMd anderson cancer centerSalarius pharmaceuticals incSalarius pharmaceuticalssalarius pharmaceuticals incDrug administrationDiamond equity research emerging growth invitationalEquity research emerging growth invitationaldateWebcast registration